Logo image of MYID.CA

REKLAIM LTD (MYID.CA) Stock Fundamental Analysis

Canada - TSX-V:MYID - CA7594021007 - Common Stock

0.08 CAD
-0.01 (-11.11%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

3

Overall MYID gets a fundamental rating of 3 out of 10. We evaluated MYID against 6 industry peers in the Professional Services industry. While MYID is still in line with the averages on profitability rating, there are concerns on its financial health. MYID has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

MYID had negative earnings in the past year.
In the past year MYID has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: MYID reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: MYID reported negative operating cash flow in multiple years.
MYID.CA Yearly Net Income VS EBIT VS OCF VS FCFMYID.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

With an excellent Return On Assets value of 20.56%, MYID belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 266.12%, MYID belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 27.43%, MYID belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA 20.56%
ROE 266.12%
ROIC 27.43%
ROA(3y)-125.18%
ROA(5y)-235.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MYID.CA Yearly ROA, ROE, ROICMYID.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

MYID has a better Profit Margin (6.04%) than 66.67% of its industry peers.
MYID has a Operating Margin of 5.41%. This is comparable to the rest of the industry: MYID outperforms 50.00% of its industry peers.
The Gross Margin of MYID (81.62%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of MYID has grown nicely.
Industry RankSector Rank
OM 5.41%
PM (TTM) 6.04%
GM 81.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y4.49%
MYID.CA Yearly Profit, Operating, Gross MarginsMYID.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MYID is creating value.
MYID has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MYID has more shares outstanding
The debt/assets ratio for MYID has been reduced compared to a year ago.
MYID.CA Yearly Shares OutstandingMYID.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MYID.CA Yearly Total Debt VS Total AssetsMYID.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

2.2 Solvency

MYID has an Altman-Z score of -19.68. This is a bad value and indicates that MYID is not financially healthy and even has some risk of bankruptcy.
MYID has a worse Altman-Z score (-19.68) than 83.33% of its industry peers.
A Debt/Equity ratio of 5.25 is on the high side and indicates that MYID has dependencies on debt financing.
MYID has a Debt to Equity ratio of 5.25. This is amonst the worse of the industry: MYID underperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.25
Debt/FCF N/A
Altman-Z -19.68
ROIC/WACC3.23
WACC8.48%
MYID.CA Yearly LT Debt VS Equity VS FCFMYID.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

2.3 Liquidity

A Current Ratio of 1.91 indicates that MYID should not have too much problems paying its short term obligations.
The Current ratio of MYID (1.91) is better than 100.00% of its industry peers.
MYID has a Quick Ratio of 1.91. This is a normal value and indicates that MYID is financially healthy and should not expect problems in meeting its short term obligations.
MYID has a Quick ratio of 1.91. This is amongst the best in the industry. MYID outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.91
MYID.CA Yearly Current Assets VS Current LiabilitesMYID.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MYID have decreased strongly by -67.90% in the last year.
Looking at the last year, MYID shows a very strong growth in Revenue. The Revenue has grown by 36.53%.
Measured over the past years, MYID shows a very strong growth in Revenue. The Revenue has been growing by 183.58% on average per year.
EPS 1Y (TTM)-67.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)36.53%
Revenue growth 3Y71.89%
Revenue growth 5Y183.58%
Sales Q2Q%73.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MYID.CA Yearly Revenue VS EstimatesMYID.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
MYID.CA Price Earnings VS Forward Price EarningsMYID.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

66.67% of the companies in the same industry are cheaper than MYID, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.57
MYID.CA Per share dataMYID.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02 0.03 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYID!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REKLAIM LTD

TSX-V:MYID (9/12/2025, 7:00:00 PM)

0.08

-0.01 (-11.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-18 2025-08-18
Earnings (Next)11-12 2025-11-12
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.75%
Ins Owner ChangeN/A
Market Cap10.15M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.81
P/FCF N/A
P/OCF N/A
P/B 79.59
P/tB 79.59
EV/EBITDA 33.57
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.04
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 20.56%
ROE 266.12%
ROCE 38.09%
ROIC 27.43%
ROICexc 48.91%
ROICexgc 48.91%
OM 5.41%
PM (TTM) 6.04%
GM 81.62%
FCFM N/A
ROA(3y)-125.18%
ROA(5y)-235.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y4.49%
F-Score3
Asset Turnover3.4
Health
Industry RankSector Rank
Debt/Equity 5.25
Debt/FCF N/A
Debt/EBITDA 2.11
Cap/Depr 95.71%
Cap/Sales 0.24%
Interest Coverage 3.92
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 1.91
Altman-Z -19.68
F-Score3
WACC8.48%
ROIC/WACC3.23
Cap/Depr(3y)39.35%
Cap/Depr(5y)50.28%
Cap/Sales(3y)0.14%
Cap/Sales(5y)1.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)36.53%
Revenue growth 3Y71.89%
Revenue growth 5Y183.58%
Sales Q2Q%73.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.61%
OCF growth 3YN/A
OCF growth 5YN/A